El interés en corto de Tungray Technologies da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Tungray Technologies. Los datos de interés en corto se actualizan cada dos semanas.

Tungray Technologies (NASDAQ:TRSG) Bolsa, Informe de interés en corto

Tungray Technologies

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

Tungray Technologies Inc - Class A Ordinary Shares

Tungray Technologies Inc

Allbirds (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIRD#NASDAQ">BIRD</a>) reported quarterly losses of $(2.73) per share which missed the analyst consensus estimate of $(2.21) by 23.53 percent. This is a 22.44 percent increase over losses of $(3.52) per share from the same period last year. The company reported quarterly sales of $32.11 million which missed the analyst consensus estimate of $44.02 million by 27.05 percent. This is a 18.34 percent decrease over sales of $39.33 million the same period last year.

Earnings

Earnings Misses

News

BIRD

Allbirds Q1 GAAP EPS $(2.73) Misses $(2.21) Estimate, Sales $32.11M Miss $44.02M Estimate

Caribou Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBU#NASDAQ">CRBU</a>) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.44) by 2.27 percent. This is a 6.52 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $2.35 million which beat the analyst consensus estimate of $1.75 million by 34.46 percent. This is a 3.13 percent decrease over sales of $2.43 million the same period last year.

Earnings Beats

CRBU

Caribou Biosciences Q1 EPS $(0.43) Beats $(0.44) Estimate, Sales $2.35M Beat $1.75M Estimate

The Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which follows the Nasdaq 100 Index, jumped 1.2% Thursday as a combination of political and economic events lifted investor mood and stoked interest in megacap tech stocks again. The Nasdaq 100 rose by almost 2%, supporting QQQ in beating <a href="https://www.benzinga.com/etfs">broad-market peers</a> on a day characterized by increased demand for risk assets.
QQQ Vs. ONEQ
The Invesco QQQ ETF continues to be a popular vehicle for those looking for concentrated exposure to the largest growth and non-financial technology stocks in the U.S., such as heavyweights Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>). Famous for its tech-heavy bias and high liquidity, QQQ tends to rise with market enthusiasm around innovation, deregulation and macroeconomic catalysts.
A similar fund, the Fidelity Nasdaq Composite Index ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEQ#NASDAQ">ONEQ</a>), provides more coverage by tracking the entire Nasdaq Composite Index, including more than 3,000 stocks of a wider group of sectors and market caps. While QQQ tends to be more volatile because of its concentration on megacap tech, ONEQ, which also rose more than 1% on Thursday, provides more diversified exposure, possibly ironing out performance through sector-specific dips. Both ETFs gauge investor attitudes toward growth and technology, but QQQ is still the more aggressive bet for investors betting large on the tech industry&#8217;s upside.
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45299690/oil-etfs-heat-up-as-opec-pump-up-us-uk-trade-deal-china-talks-fuel-rally">Oil ETFs Heat Up As OPEC+ Pump-Up, US-UK Trade Deal, China Talks Fuel Rally</a>
What Drove QQQ Today?
A focal point in Thursday&#8217;s upsurge was the declaration of the <a href="https://www.benzinga.com/25/05/45294428/wall-street-rallies-after-us-seals-first-trade-deal-you-better-go-out-and-buy-stock-trump-says">U.S.-U.K. trade agreement</a>, which, while symbolic in parts, signaled markets that geopolitical relationships could be stabilizing. The agreement includes lowering tariffs on vehicles produced in the UK and British counter purchases of U.S. products, including Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) planes. Although important tariff levels, in particular a 10% across-the-board levy, are untouched, investors saw the news as a move in the direction of wider global coordination.
Moreover, the impending talks with China scheduled for May 10 are also keeping hopes up.
Meanwhile, markets cheered initially on news the Trump administration would roll back <a href="https://www.benzinga.com/news/global/25/05/45269811/chip-stocks-rise-as-trump-reportedly-plans-to-roll-back-biden-era-ai-export-curbs">Biden-era restrictions on AI chip exports</a>. The likelihood of a rollback sent semiconductor shares, such as Nvidia, AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) and Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), showing afternoon gains of over 1%. Because the Nasdaq-100 index is heavily invested in the semiconductor space, QQQ directly took advantage of the rally. The hope of reduced AI chip sales restrictions eased concerns over a deceleration in global semiconductor demand, one of the index&#8217;s major growth pillars.
Federal Reserve Chairman Jerome Powell moderated some of the euphoria with a warning note, cautioning that an imbalanced tariff policy could increase inflationary pressures and drag on economic growth. Nevertheless, risk-on sentiment dominated after Trump&#8217;s declaration that the U.S. economy is ready for &#8220;the biggest tax cuts in history&#8221; and his firm urging investors to &#8220;go out and buy stock.&#8221;
Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), another QQQ heavyweight, gained 2% after the company addressed fears of waning search queries on Apple platforms—a clarification that regained some lost ground in the previous session&#8217;s 7% decline.
These advances combined renewed faith in U.S. technology stocks and validated the QQQ ETF&#8217;s role as a barometer of optimism in the market for innovation, deregulation, and growth-oriented policy realignments. Amidst investors scrutinizing headlines that spanned from geopolitics to generative AI, QQQ became an investors&#8217; go-to vehicle for beta exposure in a tech-fueled bounce-back — cementing its place not only as a passive index fund tracker but also as a sentiment litmus test for the direction of U.S. innovation.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/05/45293109/are-your-health-care-etfs-safe-trumps-new-policies-may-trigger-shockwaves-across-pharma-stock">Are Your Health Care ETFs Safe? Trump&#8217;s New Policies May Trigger Shockwaves Across Pharma Stocks</a></li>
</ul>

Broad U.S. Equity ETFs

ETFs

AAPL

AVGO

GOOGL

MSFT

NVDA

Fidelity NASDAQmposite Index Fund ETF-Tracking NASDAQmposite Index

ONEQ

Trump Talks Tariffs, Tech Stocks Gain As QQQ Leads The Charge

American Healthcare REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>) raises FY2025 FFO guidance from $1.56-$1.60 to $1.58-$1.64 vs $1.58 analyst estimate..

Guidance

American Healthcare REIT Raises FY2025 FFO Guidance from $1.56-$1.60 to $1.58-$1.64 vs $1.58 Est

WIIM

AMN Healthcare Services shares are trading higher after the company reported better-than-expected Q1 financial results.

MCK stock has given up its prior gain. McKesson shares were trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY26 adjusted EPS guidance with its midpoint above estimates.

SGBX

Safe & Green Holdings shares are trading lower after the company filed to sell 989.8 million shares of common stock

American Healthcares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHR#NYSE">AHR</a>) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.36 by 5.56 percent. This is a 26.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $540.60 million which beat the analyst consensus estimate of $535.31 million by 0.99 percent. This is a 8.22 percent increase over sales of $499.53 million the same period last year.

American Healthcares Q1 FFO $0.38 Beats $0.36 Estimate, Sales $540.60M Beat $535.31M Estimate

ARKO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKO#NASDAQ">ARKO</a>) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 500 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $1.83 billion which missed the analyst consensus estimate of $1.84 billion by 0.45 percent. This is a 11.73 percent decrease over sales of $2.07 billion the same period last year.

ARKO

ARKO Q1 GAAP EPS $(0.12) Beats $(0.17) Estimate, Sales $1.83B Miss $1.84B Estimate

Cardiff Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDF#NASDAQ">CRDF</a>) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 9.09 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $109.00 thousand which beat the analyst consensus estimate of $96.43 thousand by 13.04 percent. This is a 46.83 percent decrease over sales of $205.00 thousand the same period last year.

CRDF

Cardiff Oncology Q1 EPS $(0.20) Misses $(0.19) Estimate, Sales $109.00K Beat $96.43K Estimate

FIGS

FIGS shares are trading lower. The company reported Q1 financial results.

Profound Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROF#NASDAQ">PROF</a>) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.28) by 28.57 percent. This is a 38.46 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $2.62 million which missed the analyst consensus estimate of $3.50 million by 25.11 percent. This is a 37.23 percent increase over sales of $1.91 million the same period last year.

PROF

Profound Medical Q1 EPS $(0.36) Misses $(0.28) Estimate, Sales $2.62M Miss $3.50M Estimate

FLWS

1-800-FLOWERS.COM shares are trading lower after the company reported worse-than-expected Q3 financial results.

Superior Group of Companies shares are trading lower after the company reported worse-than-expected Q1 financial results

Innodata (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOD#NASDAQ">INOD</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.17 by 29.41 percent. This is a 633.33 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $58.30 million which beat the analyst consensus estimate of $57.65 million by 1.13 percent. This is a 119.97 percent increase over sales of $26.50 million the same period last year.

INOD

Innodata Q1 EPS $0.22 Beats $0.17 Estimate, Sales $58.30M Beat $57.65M Estimate

Whitehawk Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHWK#NASDAQ">WHWK</a>) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $(0.46) by 497.83 percent. This is a 369.12 percent increase over losses of $(0.68) per share from the same period last year. The company reported $7.14 million in sales this quarter. This is a 33.48 percent increase over sales of $5.35 million the same period last year.

WHWK

Whitehawk Therapeutics Q1 EPS $1.83 Beats $(0.46) Estimate, Sales $7.14M Up From $5.35M YoY

SANUWAVE Health (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SNWV#OTC">SNWV</a>) reported quarterly losses of $(0.66) per share. This is a 54.79 percent increase over losses of $(1.46) per share from the same period last year. The company reported $9.34 million in sales this quarter. This is a 61.46 percent increase over sales of $5.79 million the same period last year.

SNWV

SANUWAVE Health Q1 EPS $(0.66) Up From $(1.46) YoY, Sales $9.34M Up From $5.79M YoY

Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) affirms FY2025 sales outlook from $70.00 million-$75.00 million to $70.00 million-$75.00 million vs $72.13 million estimate.

SGHT

Sight Sciences Affirms FY2025 Sales Guidance of $70.00M-$75.00M vs $72.13M Est

Good Times Restaurants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTIM#NASDAQ">GTIM</a>) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $34.28 million in sales this quarter. This is a 3.30 percent decrease over sales of $35.45 million the same period last year.

GTIM

Good Times Restaurants Q2 EPS $(0.06) Down From $0.06 YoY, Sales $34.28M Down From $35.45M YoY

SKIN

The Beauty Health Company shares are trading higher after the company reported better-than-expected Q1 financial results

Legal

Press Releases

TRSG Announcement: If You Have Suffered Losses in Tungray Technologies Inc (NASDAQ: TRSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TRSG Investor News: Rosen Law Firm Encourages Tungray Technologies Inc Investors to Inquire About Securities Class Action Investigation - TRSG

TRSG Investor News: If You Have Suffered Losses in Tungray Technologies Inc (NASDAQ: TRSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Comments

Tungray Technologies

Interés en corto

Tungray Technologies (NASDAQ:TRSG) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL